Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

157.40
Delayed Data
As of Mar 31
 +1.22 / +0.78%
Today’s Change
94.75
Today|||52-Week Range
160.25
+15.30%
Year-to-Date
bluebird (BLUE) Down on Updates on SCD Therapy, Reports Q4
Mar 31 / Zacks.com - Paid Partner Content
Viking (VKTX) Announces Clinical Data for Metabolic Disorders
Mar 29 / Zacks.com - Paid Partner Content
Here's Why Investors Should Hold Ensign Group (ENSG) Stock Now
Mar 31 / Zacks.com - Paid Partner Content
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run
Mar 29 / MotleyFool.com - Paid Partner Content
Scynexis (SCYX) Inks Antifungal Drug Deal With GSK
Mar 31 / Zacks.com - Paid Partner Content
Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%?
Mar 29 / MotleyFool.com - Paid Partner Content
Only Electric Autos in 10 Years' Time?
Mar 30 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Gains As Market Dips: What You Should Know
Mar 28 / Zacks.com - Paid Partner Content
3 Stocks That Could Benefit From the Ozempic Craze
Mar 30 / MotleyFool.com - Paid Partner Content
Bristol Myers (BMY) Gets Approval of Psoriasis Drug in EU
Mar 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close156.18
Today’s open158.72
Day’s range157.40 - 160.25
Volume1,888
Average volume (3 months)14,265
Market cap$269.6B
Data as of 03/31/2023

Growth & Valuation

Earnings growth (last year)+4.77%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+11.71%
P/E ratio--
Price/Sales12.24
Price/Book29.56

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$25.0B
Annual profit (last year)$7.8B
Net profit margin31.38%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Chart unavailable